Patient-derived melanoma models

被引:1
|
作者
Karras, Franziska [1 ]
Kunz, Manfred [2 ]
机构
[1] Otto von Guericke Univ, Inst Pathol, Leipziger Str 44, D-39120 Magdeburg, Germany
[2] Univ Med Ctr Leipzig, Dept Dermatol Venereol & Allergol, Philipp Rosenthal Str 23, D-04103 Leipzig, Germany
关键词
Melanoma; Patient -derived models; 2D; 3D; PDX; ADVANCED BRAF(V600)-MUTANT MELANOMA; B-RAF; IMPEDANCE SPECTROSCOPY; XENOGRAFT MODELS; SKIN-EQUIVALENT; CELL-MIGRATION; MAPK PATHWAY; DOUBLE-BLIND; EX-VIVO; CANCER;
D O I
10.1016/j.prp.2024.155231
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Melanoma is a very aggressive, rapidly metastasizing tumor that has been studied intensively in the past regarding the underlying genetic and molecular mechanisms. More recently developed treatment modalities have improved response rates and overall survival of patients. However, the majority of patients suffer from secondary treatment resistance, which requires in depth analyses of the underlying mechanisms. Here, melanoma models based on patients-derived material may play an important role. Consequently, a plethora of different experimental techniques have been developed in the past years. Among these are 3D and 4D culture techniques, organotypic skin reconstructs, melanoma-on-chip models and patient-derived xenografts, Every technique has its own strengths but also weaknesses regarding throughput, reproducibility, and reflection of the human situation. Here, we provide a comprehensive overview of currently used techniques and discuss their use in different experimental settings.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Patient-derived tumor xenograft models for melanoma drug discovery
    Harris, Antoneicka L.
    Joseph, Richard W.
    Copland, John A.
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (09) : 895 - 906
  • [2] Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma
    Hoffman, Robert M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09):
  • [3] A Melanoma Patient-Derived Xenograft Model
    Xiao, Min
    Rebecca, Vito W.
    Herlyn, Meenhard
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (147):
  • [4] Patient-derived models: Advanced tools for precision medicine in neuroblastoma
    Aaltonen, Kristina
    Radke, Katarzyna
    Adamska, Aleksandra
    Seger, Alexandra
    Manas, Adriana
    Bexell, Daniel
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [5] Patient-derived cancer models: Valuable platforms for anticancer drug testing
    Genta, Sofia
    Coburn, Bryan
    Cescon, David W.
    Spreafico, Anna
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Role of Patient-Derived Models of Cancer in Translational Oncology
    Idrisova, K. F.
    Simon, H. -U.
    Gomzikova, M. O.
    CANCERS, 2023, 15 (01)
  • [7] Establishment and characterization of melanoma patient-derived xenograft models for preclinical evaluation of novel therapeutics
    Yan, Junya
    Wu, Xiaowen
    Yu, Jiayi
    Ma, Meng
    Yu, Huan
    Xu, Tianxiao
    Tang, Huan
    Xu, Longwen
    Dai, Jie
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Cui, Chuanliang
    Guo, Jun
    Kong, Yan
    MELANOMA RESEARCH, 2018, 28 (06) : 527 - 535
  • [8] PLX4032 resistance of patient-derived melanoma cells: crucial role of oxidative metabolism
    Garbarino, Ombretta
    Valenti, Giulia Elda
    Monteleone, Lorenzo
    Pietra, Gabriella
    Mingari, Maria Cristina
    Benzi, Andrea
    Bruzzone, Santina
    Ravera, Silvia
    Leardi, Riccardo
    Farinini, Emanuele
    Vernazza, Stefania
    Grottoli, Melania
    Marengo, Barbara
    Domenicotti, Cinzia
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Patient-derived xenograft models for the study of benign human neoplasms
    de Souza, Juliana Cristina
    Miguita, Lucyene
    Gomez, Ricardo Santiago
    Gomes, Carolina Cavalieri
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2021, 120
  • [10] Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
    Einarsdottir, Berglind O.
    Bagge, Roger Olofsson
    Bhadury, Joydeep
    Jespersen, Henrik
    Mattsson, Jan
    Nilsson, Lisa M.
    Truve, Katarina
    Lopez, Marcela Davila
    Naredi, Peter
    Nilsson, Ola
    Stierner, Ulrika
    Ny, Lars
    Nilsson, Jonas A.
    ONCOTARGET, 2014, 5 (20) : 9609 - 9618